Text this: A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

            ______   __   _    __   __   ______   
    ___    /_   _// | || | ||  \ \\/ // |      \\ 
   /   ||   -| ||-  | '--' ||   \ ` //  |  --  // 
  | [] ||   _| ||_  | .--. ||    | ||   |  --  \\ 
   \__ ||  /_____// |_|| |_||    |_||   |______// 
    -|_||  `-----`  `-`  `-`     `-`'   `------`  
     `-`